Advanced Biomed Cash Flow Statement (2023-2025) | ADVB

Cash Flow Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -0.15M-1.06M-0.81M-0.27M-0.33M-1.38M-0.70M-0.39M-0.14M
Depreciation and Depletion (Quarter) 0.06M0.05M0.12M0.07M0.02M0.05M0.04M0.05M0.01M
Gains from Investment Securities (Quarter) -409.00-0.01M-0.01M0.01M
Cash from Operations (Quarter) -1.07M-0.48M-0.03M-0.44M-3.81M-1.54M-0.61M0.36M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.06M0.08M0.15M0.10M-0.06M0.23M0.06M0.05M-0.01M
Change in Working Capital
Change in Accured Expenses (Quarter) -0.08M0.18M0.17M-0.13M0.06M-0.22M-0.23M-0.10M
Other Working Capital Changes (Quarter) 0.01M0.01M0.04M-0.04M-246.00-0.03M0.01M-0.66M
Investing Activities
Capital Expenditures (Quarter) -0.03M0.05M0.02M-0.01M0.00M0.02M0.00M0.01M
Cash from Investing Activities (Quarter) 0.03M-0.05M-0.02M0.01M-0.00M-0.02M-0.00M-0.01M
Financing Activities
Cash from Financing Activities (Quarter) 0.56M0.32M0.39M0.41M5.90M-0.77M0.45M-0.33M
Additional items
Exchange Rate Effect (Quarter) 0.36M0.15M-0.30M0.37M0.10M0.05M-0.08M-0.04M
Change in Cash (Quarter) -0.11M-0.06M0.04M0.01M2.53M-2.28M-0.25M-0.05M
Beginning Cash Balance (Quarter) 0.05M0.55M0.01M0.01M
Free Cash Flow (Quarter) -1.04M-0.53M-0.05M-0.43M-3.81M-1.56M-0.61M0.35M
Net Cash Flow (Quarter) -0.48M-0.21M0.34M-0.03M2.09M-2.33M-0.16M0.02M